Banner image
| More

Trade and investment narratives

Further narratives have been developed to bring the messages to life and illustrate how they can be tweaked for different audiences - in this case, trade and investment. They have been developed from the same set of core messages and evidence, but aim to tell slightly different stories and appeal to different needs and concerns.

    Trade narrative

    With its track record of world-class research, the UK life sciences industry produces highly innovative, effective solutions to global and local health issues, bringing together funding from private and public sources to accelerate the flow of innovation and create routes to market through scientific and business collaboration.

    The talent and skills available to the UK life sciences industry have played a major part in its success, delivering scientific innovation at the highest level, and using managerial leadership and experience to turn cutting-edge scientific discoveries into marketable products.

    The UK's dynamic business and regulatory environment provides fertile conditions for achievement in life sciences. UK regulators are respected and trusted worldwide, while effective IP protection and a vibrant business environment stimulate innovation and provide a springboard for both start-ups and established businesses.

    Investment narrative

    The UK is a superb location for global investment in life sciences, combining a track record of fast, efficient and profitable product development with a world-class scientific research base, access to publicly-funded support and proven routes to market.

    The UK's success in the life sciences has been driven by its rich pool of talent and skills - ranging from world-class scientific institutions and impressive research base, to the managerial and leadership capabilities which foster effective, profitable exploitation of scientific innovation.

    The UK has created a stimulating and supportive business environment for life sciences, with the government working in partnership with industry to drive scientific innovation through to market success. The UK's trusted regulatory environment, open-minded and diverse culture, as well as innovation-friendly IP laws, help create a profitable springboard for many of the world's leading life science organisations.

    Providing lifelong care for a socially and ethnically diverse population of 60 million people, the NHS acts as an effective incubator of life sciences achievement, boosted by its close relationship with UK universities, emphasis on innovation and focus on progress in translational medicine.

    The UK's infrastructure provides end-to-end benefits for trade and investment partnerships, including highly-regarded life sciences institutions, strong manufacturing and supply-chain capabilities, world-class professional services and superb access to global markets.

    Drawing on world-class science and technology and entrepreneurial, dynamic management, the UK provides one of the best financial and business environment for investment in the life sciences. It provides investors with access to high-quality life sciences companies at all stages of growth, together with a range of different investment vehicles and sophisticated specialist investors to partner with.

Trade and investment narrative in Japanese
Trade and investment narrative in Chinese